---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-001759"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2022-02-16T23:59:59+00:00"
generated_at: "2026-06-27T07:22:13.630054+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience appoints BDO as auditor and finalizes CEO John Payne's employment contract

## Summary
- Appointed BDO USA, LLP as independent auditor effective February 10, 2022, replacing resigned auditor Wolinetz, Lafazan & Company.
- CEO John Payne's contract provides $400k annual salary, bonus up to 125% of salary, and annual equity awards valued at $400k.
- ZIVO 2021 Plan reserves 1,000,000 shares with automatic annual increase of 5% of outstanding shares through 2031.

## SEC filing metadata
- accession: 0001654954-22-001759
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2022-02-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 4.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495422001759/0001654954-22-001759-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495422001759/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-001759
- JSON: https://secwatch.observer/filing/0001654954-22-001759.json
- Plain text: https://secwatch.observer/filing/0001654954-22-001759.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.